Catheter Precision Inc. (NYSE AMERICAN: VTAK) Stock Information | RedChip

Catheter Precision Inc. (NYSE AMERICAN: VTAK)


$3.05
-0.7800 ( -20.40% ) 260.7K

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Market Data


Open


$3.05

Previous close


$3.83

Volume


260.7K

Market cap


$26.17M

Day range


$0.91 - $3.64

52 week range


$0.91 - $8.40

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Jul 14, 2023
8-k 8K-related 14 Jul 07, 2023

Latest News